Clinical Trial Update: Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intravesical adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) for BCG-exposed high-grade non-muscle invasive u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Intravesical adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) (tumor-infiltrating lymphocytes (TIL))

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING